Rekvina Laboratories Ltd (VINRKLB)

Overview

Rekvina Laboratories Ltd. is a prominent Indian pharmaceutical company that has evolved significantly since its inception in the mid-1980s. Originally starting as a small domestic entity, it has grown to become a key player in the healthcare sector, dedicated to providing quality medications at competitive prices. The company is particularly focused on developing and marketing pharmaceutical formulations, with a strong specialization in gynecological disorders and surgical therapeutic segments. Upholding rigorous standards such as WHO-GMP and cGMP certifications, Rekvina Laboratories ensures product excellence and adherence to regulatory requirements.

In addition to its commitment to quality, the company prioritizes process innovation, aiming to achieve cost advantages while also emphasizing environmental protection and waste minimization. By providing substantial customer value through technical support and in-depth analytical data, Rekvina Laboratories is poised for ambitious expansion efforts. With its headquarters situated in Vadodara, Gujarat, the firm seeks to penetrate various domestic markets across India and extend its reach into international areas including Eastern Asia, Europe, Africa, and the Middle East. Furthermore, Rekvina Laboratories actively invests in research and development, pursues drug discovery collaborations, and plans the development of sophisticated formulations alongside life-saving medicines. Their strategic aim is to rank among India's top 100 pharmaceutical companies through a combination of organic growth and targeted acquisitions.

Products and Services

• Pharmaceutical Formulations: Rekvina Laboratories manufactures a wide range of pharmaceutical formulations tailored to meet the varying needs of patients. This includes medications designed to address gynecological disorders, ensuring that their products meet both efficacy and safety standards.
• Surgical Therapeutic Products: The company's offerings in surgical therapeutic segments encompass essential medications that support surgeries and post-operative care, bolstering recovery and enhancing patient outcomes.
• Research and Development: Rekvina Laboratories is heavily invested in R&D initiatives to drive innovation in drug formulations. This commitment includes significant resource allocation toward discovering new drugs that can potentially address unmet medical needs.
• Technical Support Services: Beyond product offerings, the company provides extensive technical support, ensuring healthcare professionals have the necessary resources to use their medications effectively. This includes detailed analytical data that supports informed decision-making.
• Environmental and Process Innovation: The firm is dedicated to sustainable practices, focusing on process innovation to not only streamline manufacturing but also minimize environmental impact and reduce waste throughout their operations.
• Expansion Initiatives: Rekvina Laboratories has laid out ambitious plans for expansion into both domestic and international markets, which will involve scaling their production capabilities and enhancing their marketing strategies to reach new customers.